Document is current
Any future updates will be listed below
-
Authors
Zanou, Nadège https://orcid.org/0000-0001-6626-3127
Dridi, Haikel https://orcid.org/0000-0001-9533-7367
Reiken, Steven
Imamura de Lima, Tanes
Donnelly, Chris https://orcid.org/0000-0002-5392-7876
De Marchi, Umberto https://orcid.org/0000-0002-6011-5446
Ferrini, Manuele https://orcid.org/0000-0001-8291-6618
Vidal, Jeremy
Sittenfeld, Leah
Feige, Jerome N. https://orcid.org/0000-0002-4751-264X
Garcia-Roves, Pablo M. https://orcid.org/0000-0002-8371-2067
Lopez-Mejia, Isabel C. https://orcid.org/0000-0001-5918-0227
Marks, Andrew R.
Auwerx, Johan https://orcid.org/0000-0002-5065-5393
Kayser, Bengt https://orcid.org/0000-0002-9776-7501
Place, Nicolas https://orcid.org/0000-0001-9044-0621
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF Grant n° IZK0Z3_173941, SNF Grant n° 194964, Ambizione PZ00P3_168077, PRIMA PR00P3_193166)
Université de Lausanne (Subside Tremplin, Relève académique)
Universidade de Brasília (FAPESP (2019/11171-7))
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Grant PI15/00701)
Funder: European Regional Development Fund ‘A way to build Europe’’
Foundation for the National Institutes of Health (R01HL145473, R01DK118240, R01HL142903, R01HL061503, R01HL140934, R01AR070194)
Stiftung für die Erforschung der Muskelkrankheiten
Funders: - Ecole polytechnique fédérale de Lausanne - Fondation Marcel Levaillant
- License Information
-
More Information
Article History
Received: 21 July 2020
Accepted: 18 November 2021
First Online: 10 December 2021
Competing interests
: U.D.M. and J.N.F. are employees of Nestlé Research, which is part of the Société des Produits Nestlé SA. A.R.M. is chair of the SAB and holds stock in ARMGO Pharma Inc., a biotech company developing drugs targeting RyR channel leak. The remaining authors declare no competing interests.
